Oct 2026
ctDNA clearance and outcomes for resectable lung cancer from NeoCOAST-2.
Findings suggest combined assessment of ctDNA clearance and pCR may improve risk stratification, and that the numerically highest pCR4 and EFS rates with the Dato-DXd combination warrant further evaluation.
L. McGrath, Gozde Kar, L. Bonanno et al.
· Nature · 0 citations